CAS 63610-08-2|Indobufen

Introduction:Basic information about CAS 63610-08-2|Indobufen, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
Common NameIndobufen
CAS Number63610-08-2Molecular Weight295.33
Density1.3±0.1 g/cm3Boiling Point518.1±50.0 °C at 760 mmHg
Molecular FormulaC18H17NO3Melting Point33-34 °C(lit.)
MSDS/Flash Point267.1±30.1 °C

Names

Name2-[4-(3-oxo-1H-isoindol-2-yl)phenyl]butanoic acid
SynonymMore Synonyms

Indobufen BiologicalActivity

DescriptionIndobufen is a platelet aggregation inhibitor. Indobufen is a reversible platelet cyclooxygenase (Cox) activity inhibitor. Indobufen suppresses thromboxane A2 (TxA2) synthesis. Indobufen down-regulates tissue factor (TF) in monocytes[1].
Related CatalogResearch Areas >>Cardiovascular DiseaseSignaling Pathways >>Immunology/Inflammation >>COX
Target

COX

In VitroIndobufen does not affect both Cox-1 and Cox-2 protein, whereas Indobufen reduces TxB2 levels. Indobufen inhibits TxA2 but not PGE2 synthesis in LPS-stimulated monocytes. Indobufen reduces the extent of ERK1/2 phosphorylation, whereas the levels of phosphorylated p38 are unaltered[1].
References

[1]. Eligini S, et al. Indobufen inhibits tissue factor in human monocytes through a thromboxane-mediated mechanism. Cardiovasc Res. 2006 Jan;69(1):218-26.

Chemical & Physical Properties

Density1.3±0.1 g/cm3
Boiling Point518.1±50.0 °C at 760 mmHg
Melting Point33-34 °C(lit.)
Molecular FormulaC18H17NO3
Molecular Weight295.33
Flash Point267.1±30.1 °C
Exact Mass295.120850
PSA57.61000
LogP3.30
Vapour Pressure0.0±1.4 mmHg at 25°C
Index of Refraction1.630
InChIKeyAYDXAULLCROVIT-UHFFFAOYSA-N
SMILESCCC(C(=O)O)c1ccc(N2Cc3ccccc3C2=O)cc1

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
ET5955800
CHEMICAL NAME :
Butyric acid, 2-(p-(1-oxo-2-isoindolinyl)phenyl)-, (+-)-
CAS REGISTRY NUMBER :
63610-08-2
LAST UPDATED :
199710
DATA ITEMS CITED :
8
MOLECULAR FORMULA :
C18-H17-N-O3
MOLECULAR WEIGHT :
295.36
WISWESSER LINE NOTATION :
T56 BVN DHJ CR DY2&VQ

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
373 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 4,109,1979
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
345 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 4,109,1979
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
333 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 4,109,1979
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
697 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 4,109,1979
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
365 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 4,109,1979
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
370 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 4,109,1979

Safety Information

WGK Germany3
HS Code2942000000

Customs

HS Code2918300090
Summary2918300090 other carboxylic acids with aldehyde or ketone function but without other oxygen function, their anhydrides, halides, peroxides, peroxyacids and their derivatives。Supervision conditions:None。VAT:17.0%。Tax rebate rate:9.0%。MFN tariff:6.5%。General tariff:30.0%

Synonyms

4-(1,3-Dihydro-1-oxo-2H-isoindol-2-yl)-α-ethyl-benzeneacetic acid
Benzeneacetic acid, 4-(1,3-dihydro-1-oxo-2H-isoindol-2-yl)-α-ethyl-, (±)-
(±)-4-(1,3-Dihydro-1-oxo-2H-isoindol-2-yl)-a-ethylbenzeneacetic Acid
2-[4-(1-Oxo-1,3-dihydro-isoindol-2
MFCD00572250
2-[4-(1-Oxo-1,3-dihydro-2H-isoindol-2-yl)phenyl]butanoic acid
Benzeneacetic acid, 4-(1,3-dihydro-1-oxo-2H-isoindol-2-yl)-α-ethyl-
K-3920
UNII-6T9949G4LZ
1-Oxo-2-[p-[(a-ethyl)carboxymethyl]phenyl]isoindoline
EINECS 264-364-4
2-(4-(1-Oxo-2-isoindolinyl)phenyl)butyric acid
Ibustrin
1-Oxo-2-(p-((α-ethyl)carboxymethyl)phenyl)isoindoline
2-[4-(1-Carboxypropyl)phenyl]-1-isoindolinone
(±)-2-[p-(1-Oxo-2-isoindolinyl)phenyl]butyric Acid
Butyric acid, 2-(p-(1-oxo-2-isoindolinyl)phenyl)-, (±)-
Indobufen
2-[4-(1-oxo-1,3-dihydro-isoindol-2-yl)-phenyl]-butyric acid
2-(4-(1-oxoisoindolin-2-yl)phenyl)butanoic acid
Indobufen (INN)
(±)-2-(p-(1-Oxo-2-isoindolinyl)phenyl)butyric acid
CAS 183507-85-9|(R)-1-(Naphthalen-1-yl)-N-((S)-1-phenylethyl)ethanamine
CAS 52709-84-9|4-cyano-4'-octylbiphenyl
Recommended......
TOP